Inventor · disambiguated record
Sridhar Krishna Rabindran
Also filed as: RABINDRAN SRIDHAR · RABINDRAN SRIDHAR K · RABINDRAN SRIDHAR KRISHNA
10 granted patents·8 pending applications·199 citations·filing 1994–2022
90Inventor score
Top patents by PatentIndex Score
18 records- 0196US6617333B2Antineoplastic combinations comprisingWYETH CORP·Filed 2002·Granted Sep 9, 2003·109 cites·27 claims
- 0295US7399865B2Protein tyrosine kinase enzyme inhibitorsWYETH CORP·Filed 2004·Granted Jul 15, 2008·40 cites·10 claims
- 0394US7982043B2Protein tyrosine kinase enzyme inhibitorsWYETH LLC·Filed 2008·Granted Jul 19, 2011·13 cites·1 claims
- 0489USRE40418ETreatment of neoplasms with CCI-779/EKB-569 combinationWYETH CORP·Filed 2005·Granted Jul 1, 2008·14 cites·27 claims
- 0580US10596162B2Method for treating gefitinib resistant cancerWYETH LLC·Filed 2016·Granted Mar 24, 2020·3 cites·4 claims
- 0674US10603314B2Method for treating gefitinib resistant cancerHABER DANIEL A·Filed 2006·Granted Mar 31, 2020·3 cites·9 claims
- 0774US2023201155A1Antineoplastic Combinations with m-TOR Inhibitor, Trastuzumab and/or HKI-272WYETH LLC·Filed 2022·Application pending·0 cites
- 0871US2022354820A1Antineoplastic Combinations with m-TOR Inhibitor, Trastuzumab and/or HKI-272WYETH LLC·Filed 2021·Application pending·0 cites
- 0971US2023226039A1Method for treating gefitinib resistant cancerWYETH LLC·Filed 2022·Application pending·0 cites
- 1062US10729672B2Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272WYETH LLC·Filed 2013·Granted Aug 4, 2020·0 cites·14 claims
- 1162US2009297519A1ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272WYETH CORP·Filed 2009·Application pending·0 cites
- 1254US2007104721A1Antineoplastic combinations with mTOR inhibitor,herceptin, and/or hki-272WYETH CORP·Filed 2006·Application pending·0 cites
- 1353US6372775B1Reversal of multidrug resistance in human colon carcinoma cellsAMERICAN CYANAMID CO·Filed 1999·Granted Apr 16, 2002·4 cites·6 claims
- 1449US6878737B2Reversal of multidrug resistance in human colon carcinoma cellsWYETH CORP·Filed 2002·Granted Apr 12, 2005·0 cites·9 claims
- 1549US2012308560A1Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272MOORE LAURENCE·Filed 2012·Application pending·0 cites
- 1648US5756343ACell stress transcriptional factorsUS HEALTH·Filed 1994·Granted May 26, 1998·13 cites·15 claims
- 1742US2006270670A1Methods of synthesizing 6-alkylaminoquinoline derivativesCHEW WARREN·Filed 2006·Application pending·0 cites
- 1841US2008274959A1Actinomadura Chromoprotein, Apoprotein and Gene ClusterWYETH CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sridhar Krishna Rabindran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →